Longitudinal evaluation of an educational intervention for preventing tick bites in an area with endemic lyme disease in Baltimore County, Maryland

American Journal of Epidemiology

Volumn 157, Issue 11, 2003, Pages 1039-1051

  Malouin, Rebecca ^a   Winch, Peter ^a   Leontsini, Elli ^a   Glass, Gregory ^a   Simon, David ^a   Hayes, Edward B ^b   Schwartz, Brian S ^a,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biological markers; Intervention studies; Lyme disease; Randomized controlled trials; Tick borne diseases

Indexed keywords

ANTI RECOMBINANT TICK CALRETICULIN ANTIBODY; BIOLOGICAL MARKER; CALRETICULIN; INSECT REPELLENT; UNCLASSIFIED DRUG;

LYME DISEASE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; HEALTH BEHAVIOR; HEALTH EDUCATION; HUMAN; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; LYME DISEASE; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PATIENT COUNSELING; PREDICTION; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH SERVICE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TICK BITE; UNITED STATES;

EID: 0038351057     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwg076     Document Type: Article

References (38)

1. Dennis DT. Lyme disease. Dermatol Clin 1995;13:537-51.
2. Barbour AG. Fall and rise of Lyme disease and other Ixodes tick-borne infections in North America and Europe. Br Med Bull 1998;54:647-58.
3. Dumler JS, Bakken JS. Ehrlichial diseases of humans: emerging tick-borne infections. Clin Infect Dis 1995;20:1102-10.
4. Dumler JS, Bakken JS. Human ehrlichioses: newly recognized infections transmitted by ticks. Annu Rev Med 1998;49:201-13.
5. Ebel GD, Foppa I, Spielman A, et al. A focus of deer tick virus transmission in the northcentral United States. Emerg Infect Dis 1999;5:570-4.
6. Hilton E, DeVoti J, Benach JL, et al. Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States. Am J Med 1999;106:404-9.
7. Walker DH. Tick-transmitted infectious diseases in the United States. Annu Rev Public Health 1998;19:237-69.
8. Walker DH, Dumler JS. Emergence of the ehrlichioses as human health problems. Emerg Infect Dis 1996;2:18-29.
9. Frank DH, Fish D, Moy FH. Landscape features associated with Lyme disease risk in a suburban residential environment. Landscape Ecol 1998;13:27-36.
10. Lindgren E, Talleklint L, Polfeldt T. Impact of climatic change on the northern latitude limit and population density of the disease-transmitting European tick Ixodes ricinus. Environ Health Perspect 2000;108:119-23.
11. From the Centers for Disease Control and Prevention. Lyme disease-United States, 1996. JAMA 1997;278:112.
12. Recommendations for the use of Lyme disease vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1999;48:1-17, 21-5.
13. Parenti D. Lyme disease vaccine-LYMErix. (Letter). Conn Med 1999;63:570.
14. Loyd L. An end to vaccine for Lyme disease. Philadelphia Inquirer 2002;February 27:C01.
15. Cartter ML, Farley TA, Ardito HA, et al. Lyme disease prevention-knowledge, beliefs, and behaviors among high school students in an endemic area. Conn Med 1989;53:354-6.
16. Lyme disease knowledge, attitudes, and behaviors-Connecticut, 1992. MMWR Morb Mortal Wkly Rep 1992;41:505-7.
17. Mawby TV, Lovett AA. The public health risks of Lyme disease in Breckland, U.K.: an investigation of environmental and social factors. Soc Sci Med 1998;46:719-27.
18. Shadick NA, Daltroy LH, Phillips CB, et al. Determinants of tick-avoidance behaviors in an endemic area for Lyme disease. Am J Prev Med 1997;13:265-70.
19. Schwartz BS, Ribeiro JM, Goldstein MD. Anti-tick antibodies: an epidemiologic tool in Lyme disease research. Am J Epidemiol 1990;132:58-66.
20. Schwartz BS, Ford DP, Childs JE, et al. Anti-tick saliva antibody: a biologic marker of tick exposure that is a risk factor for Lyme disease seropositivity. Am J Epidemiol 1991;134:86-95.
21. Schwartz BS, Goldstein MD, Childs JE. Antibodies to Borrelia burgdorferi and tick salivary gland proteins in New Jersey outdoor workers. Am J Public Health 1993;83:1746-8.
22. Schwartz BS, Nadelman RB, Fish D, et al. Entomologic and demographic correlates of anti-tick saliva antibody in a prospective study of tick bite subjects in Westchester County, New York. Am J Trop Med Hyg 1993;48:50-7.
23. Schwartz BS, Goldstein MD, Childs JE. Longitudinal study of Borrelia burgdorferi infection in New Jersey outdoor workers, 1988-1991. Am J Epidemiol 1994;139:504-12.
24. Schwartz BS, Sanchez JL, Sanders ML, et al. Tick avoidance behaviors associated with a decreased risk of anti-tick salivary gland protein antibody seropositivity in military personnel exposed to Amblyomma americanum in Arkansas. Am J Trop Med Hyg 1996;55:410-16.
25. Lane RS, Moss RB, Hsu YP, et al. Anti-arthropod saliva antibodies among residents of a community at high risk for Lyme disease in California. Am J Trop Med Hyg 1999;61:850-9.
26. Sanders ML, Glass GE, Scott AL, et al. Kinetics and cross-species comparisons of host antibody responses to lone star ticks and American dog ticks (Acari: Ixodidae). J Med Entomol 1998;35:849-56.
27. Sanders ML, Jaworski DC, Sanchez JL, et al. Antibody to a cDNA-derived calreticulin protein from Amblyomma americanum as a biomarker of tick exposure in humans. Am J Trop Med Hyg 1998;59:279-85.
28. Sanders ML, Glass GE, Nadelman RB, et al. Antibody levels to recombinant tick calreticulin increase in humans after exposure to Ixodes scapularis (Say) and are correlated with tick engorgement indices. Am J Epidemiol 1999;149:777-84.
29. Jaworski DC, Simmen FA, Lamoreaux W, et al. A secreted calreticulin protein in Ixodid tick (Amblyomma americanum) saliva. J Insect Physiol 1995;41:369-75.
30. Glass GE, Schwartz BS, Morgan JM, et al. Environmental risk factors for Lyme disease identified with geographic information systems. Am J Public Health 1995;85:944-8.
31. SPSS, Inc. SPSS for Windows, release 7.5.1. Standard version. Chicago, IL: SPSS, Inc, 1996.
32. SAS Institute, Inc. SAS language and procedures: usage. Version 6. Cary, NC: SAS Institute, Inc, 1989.
33. Bernard HR. Research methods in anthropology. Walnut Creek, CA: AltaMira Press, 1995.
34. Devellis RF. Scale development: theory and applications. (Applied social research methods, vol 26). Newbury Park, CA: Sage Publications, 1991.
35. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-30.
36. Smith PF, Benach JL, White DJ, et al. Occupational risk of Lyme disease in endemic areas of New York State. Ann N Y Acad Sci 1988;539:289-301.
37. Sheaves BJ, Brown RW. A zoonosis as a health hazard in UK Moorland Recreational Areas: a case study of Lyme disease. J Environ Planning Manage 1995;38:201-14.
38. Phillips CB, Liang MH, Sangha O, et al. Lyme disease and preventive behaviors in residents of Nantucket Island, Massachusetts. Am J Prev Med 2001;20:219-24.